BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 51 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $183,557 | +3.2% | 2,074,551 | +1.1% | 0.32% | +9.8% |
| Q2 2023 | $177,808 | -11.2% | 2,051,316 | -0.4% | 0.29% | -17.3% |
| Q1 2023 | $200,251 | -7.4% | 2,059,347 | -1.5% | 0.35% | -19.9% |
| Q4 2022 | $216,269 | -99.9% | 2,089,754 | -4.6% | 0.43% | +15.2% |
| Q3 2022 | $185,686,000 | -1.5% | 2,190,467 | -3.7% | 0.38% | +7.4% |
| Q2 2022 | $188,489,000 | +7.3% | 2,274,521 | -0.1% | 0.35% | +48.9% |
| Q1 2022 | $175,618,000 | -13.7% | 2,277,794 | -1.2% | 0.24% | -4.5% |
| Q4 2021 | $203,602,000 | +8.5% | 2,304,490 | -5.1% | 0.25% | +6.5% |
| Q3 2021 | $187,590,000 | -5.0% | 2,427,099 | +2.6% | 0.23% | -3.3% |
| Q2 2021 | $197,478,000 | – | 2,366,716 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BANQUE PICTET & CIE SA | 6,300,000 | $637,335,229 | 5.59% |
| Wellesley Asset Management | 42,526,167 | $42,983,572 | 3.50% |
| MACKAY SHIELDS LLC | 76,286,000 | $77,072,118 | 2.16% |
| Sonora Investment Management Group, LLC | 10,960,000 | $11,124,717 | 0.93% |
| Lombard Odier Asset Management (Europe) Ltd | 16,354,000 | $16,495,299 | 0.78% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 35,695,000 | $36,062,832 | 0.70% |
| ZAZOVE ASSOCIATES LLC | 5,150,000 | $5,210 | 0.48% |
| LOOMIS SAYLES & CO L P | 2,051,316 | $177,808 | 0.29% |
| Liberty Mutual Group Asset Management Inc. | 1,025,000 | $1,030 | 0.26% |
| PIER 88 INVESTMENT PARTNERS LLC | 602,000 | $605,689 | 0.15% |